Anchyra Partners »

Context Therapeutics shares owned by Anchyra Partners

Quarter-by-quarter ownership of Context Therapeutics (CNTX) shares owned by Anchyra Partners from 13F filings

Historical chart of Anchyra Partners investment in Context Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Context Therapeutics held by Anchyra Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Context Therapeutics by Anchyra Partners

Quarter filed Position value Share count Share price at filing
2026-09-30 $3.1k 10k 0.30

More positions owned by Anchyra Partners

T. Rowe Price (TROW)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl A (GOOGL)
Ishares Tr Russell 3000 Etf (IWV)
Amazon (AMZN)
Micron Technology (MU)
Broadcom (AVGO)
Spdr Gold Tr Gold Shs (GLD)
Arista Networks Com Shs (ANET)
Navios Maritime Partners Com Unit Lpi (NMM)
Marvell Technology (MRVL)

View all positions for Anchyra Partners

Top funds holding Context Therapeutics

Nextech Invest
Deep Track Capital
Soleus Capital Management
BlackRock
Avidity Partners Management
Franklin Resources
Vanguard Capital Management
Octagon Capital Advisors
Blue Owl Capital Holdings
TCG Crossover Management
Geode Capital Management
State Street Corporation
MPM Oncology Impact Management
Renaissance Technologies
Acadian Asset Management

View all funds holding Context Therapeutics